Pharmacy
Investor Carl Icahn says he will vote against $54 billion PBM acquisition as being too high a price.
The merger would increase market concentration in the PBM space and put other insurers at a competitive disadvantage, Dave Jones says.
Announcement comes less than two months after a scathing report from the Office of the Inspector General showing skyrocketing Medicare Part D drug spending.
There may be multiple drugs on the market that have already been shown to be better than the standard, and drugs may even be approved without any comparisons.
Express Scripts is being replaced by in-house pharmacy service; Boost in volume to be mitigated through new fulfillment center and pharmacy robots.
The reports come as GSK also aligned with 23andMe on drug development work.
Communication, technology and referral management will drive success in combating opioid abuse, the Medical Group Management Association says.
While they agree with certain proposals, they take issue with others, as stated in letters the groups sent this week to HHS Secretary Alex Azar.
Whether it's technology, legislation, or new policies and programs, the healthcare industry is attacking opioid abuse from numerous angles.
Operation S.O.S. was inspired by prosecution efforts in Manatee County, Florida, which realized a 77 percent drop in overdose deaths.